94 related articles for article (PubMed ID: 23777919)
1. The in vivo performance of ferrocenyl tamoxifen lipid nanocapsules in xenografted triple negative breast cancer.
Lainé AL; Adriaenssens E; Vessières A; Jaouen G; Corbet C; Desruelles E; Pigeon P; Toillon RA; Passirani C
Biomaterials; 2013 Sep; 34(28):6949-56. PubMed ID: 23777919
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.
Allard E; Passirani C; Garcion E; Pigeon P; Vessières A; Jaouen G; Benoit JP
J Control Release; 2008 Sep; 130(2):146-53. PubMed ID: 18582507
[TBL] [Abstract][Full Text] [Related]
4. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
5. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
[TBL] [Abstract][Full Text] [Related]
6. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells.
Shemesh CS; Hardy CW; Yu DS; Fernandez B; Zhang H
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):193-203. PubMed ID: 24657627
[TBL] [Abstract][Full Text] [Related]
7. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
Benatar T; Yang W; Amemiya Y; Evdokimova V; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2012 Jun; 133(2):563-73. PubMed ID: 21997538
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment.
Nguyen A; Marsaud V; Bouclier C; Top S; Vessieres A; Pigeon P; Gref R; Legrand P; Jaouen G; Renoir JM
Int J Pharm; 2008 Jan; 347(1-2):128-35. PubMed ID: 17643877
[TBL] [Abstract][Full Text] [Related]
9. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research.
Wang K; Xie S; Ren Y; Xia H; Zhang X; He J
Oncol Rep; 2012 Jun; 27(6):1981-9. PubMed ID: 22446691
[TBL] [Abstract][Full Text] [Related]
11. Targeted chemotherapy for triple-negative breast cancers via LHRH receptor.
Föst C; Duwe F; Hellriegel M; Schweyer S; Emons G; Gründker C
Oncol Rep; 2011 May; 25(5):1481-7. PubMed ID: 21331448
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
Kutty RV; Feng SS
Biomaterials; 2013 Dec; 34(38):10160-71. PubMed ID: 24090836
[TBL] [Abstract][Full Text] [Related]
13. A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.
Vessières A; Corbet C; Heldt JM; Lories N; Jouy N; Laïos I; Leclercq G; Jaouen G; Toillon RA
J Inorg Biochem; 2010 May; 104(5):503-11. PubMed ID: 20116857
[TBL] [Abstract][Full Text] [Related]
14. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
15. An aspirin a day keeps cancer at bay?
Harrington M
Lab Anim (NY); 2013 Jul; 42(7):236. PubMed ID: 23783304
[No Abstract] [Full Text] [Related]
16. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab.
Chen JL; Wang JY; Tsai YF; Lin YH; Tseng LM; Chang WC; King KL; Chen WS; Chiu JH; Shyr YM
Menopause; 2013 Jun; 20(6):646-54. PubMed ID: 23340260
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules.
Lainé AL; Clavreul A; Rousseau A; Tétaud C; Vessieres A; Garcion E; Jaouen G; Aubert L; Guilbert M; Benoit JP; Toillon RA; Passirani C
Nanomedicine; 2014 Nov; 10(8):1667-77. PubMed ID: 24842766
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
